tiprankstipranks
Trending News
More News >
Incannex Healthcare Limited Sponsored ADR (IXHL)
NASDAQ:IXHL
US Market

Incannex Healthcare Limited Sponsored ADR (IXHL) Stock Statistics & Valuation Metrics

Compare
75 Followers

Total Valuation

Incannex Healthcare Limited Sponsored ADR has a market cap or net worth of $17.91M. The enterprise value is ―.
Market Cap$17.91M
Enterprise Value

Share Statistics

Incannex Healthcare Limited Sponsored ADR has 27,546,753 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding27,546,753
Owned by Insiders0.36%
Owned by Institutions0.69%

Financial Efficiency

Incannex Healthcare Limited Sponsored ADR’s return on equity (ROE) is -1.65 and return on invested capital (ROIC) is -259.62%.
Return on Equity (ROE)-1.65
Return on Assets (ROA)-1.08
Return on Invested Capital (ROIC)-259.62%
Return on Capital Employed (ROCE)-2.63
Revenue Per Employee1.33K
Profits Per Employee-2.05M
Employee Count9
Asset Turnover<0.01
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Incannex Healthcare Limited Sponsored ADR is -2.58. Incannex Healthcare Limited Sponsored ADR’s PEG ratio is 0.04.
PE Ratio-2.58
PS Ratio172.10
PB Ratio4.25
Price to Fair Value4.25
Price to FCF-2.96
Price to Operating Cash Flow-3.01
PEG Ratio0.04

Income Statement

In the last 12 months, Incannex Healthcare Limited Sponsored ADR had revenue of 12.00K and earned -18.46M in profits. Earnings per share was -1.14.
Revenue12.00K
Gross Profit12.00K
Operating Income-30.04M
Pretax Income-18.43M
Net Income-18.46M
EBITDA-18.50M
Earnings Per Share (EPS)-1.14

Cash Flow

In the last 12 months, operating cash flow was -7.87M and capital expenditures -5.00K, giving a free cash flow of -7.89M billion.
Operating Cash Flow-7.87M
Free Cash Flow-7.89M
Free Cash Flow per Share-0.29

Dividends & Yields

Incannex Healthcare Limited Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.07
52-Week Price Change-75.44%
50-Day Moving Average0.99
200-Day Moving Average1.74
Relative Strength Index (RSI)37.64
Average Volume (3m)243.19K

Important Dates

Incannex Healthcare Limited Sponsored ADR upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateFeb 14, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date

Financial Position

Incannex Healthcare Limited Sponsored ADR as a current ratio of 2.88, with Debt / Equity ratio of 424.56%
Current Ratio2.88
Quick Ratio2.88
Debt to Market Cap0.00
Net Debt to EBITDA0.30
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Incannex Healthcare Limited Sponsored ADR has paid 30.00K in taxes.
Income Tax30.00K
Effective Tax Rate>-0.01

Enterprise Valuation

Incannex Healthcare Limited Sponsored ADR EV to EBITDA ratio is -2.28, with an EV/FCF ratio of -2.62.
EV to Sales3.52K
EV to EBITDA-2.28
EV to Free Cash Flow-2.62
EV to Operating Cash Flow-2.66

Balance Sheet

Incannex Healthcare Limited Sponsored ADR has $2.10M in cash and marketable securities with $4.10M in debt, giving a net cash position of $2.00M billion.
Cash & Marketable Securities$2.10M
Total Debt$4.10M
Net Cash$2.00M
Net Cash Per Share$0.07
Tangible Book Value Per Share$0.69

Margins

Gross margin is 100.00%, with operating margin of -250341.67%, and net profit margin of -153825.00%.
Gross Margin100.00%
Operating Margin-250341.67%
Pretax Margin-153575.00%
Net Profit Margin-153825.00%
EBITDA Margin-154200.00%
EBIT Margin-155058.33%

Analyst Forecast

The average price target for Incannex Healthcare Limited Sponsored ADR is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score2
AI Score35
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis